A natural apolipoprotein A-I variant, apoA-I (L141R)Pisa, interferes with the formation of alpha-high density lipoproteins (HDL) but not with the formation of pre beta 1-HDL and influences efflux of cholesterol into plasma

A natural apolipoprotein A-I variant, apoA-I (L141R)Pisa, interferes with the formation of alpha-high density lipoproteins (HDL) but not with the formation of pre beta 1-HDL and influences efflux of cholesterol into plasma

ApoA-I(L141R)Pisa is a naturally occurring apolipoprotein A-I variant that causes virtual absence of HDL in hemizygotes and hypoalphalipoproteinemia with half-normal levels of HDL-cholesterol in heterozygotes. In this study we analyzed the distribution of HDL subclasses in plasmas of four hemizygote...

Full description

Bibliographic Details
Main Authors:	R Miccoli, Y Zhu, U Daum, J Wessling, Y Huang, R Navalesi, G Assmann, A von Eckardstein
Format:	Article
Language:	English
Published:	Elsevier 1997-06-01
Series:	Journal of Lipid Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520372059

Similar Items

Kinetic characteristics and regulation of HDL cholesteryl ester and apolipoprotein transport in the apoA-I-/- mouse
by: David K. Spady, et al.
Published: (1998-07-01)

HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity
by: Mark S. Borja, et al.
Published: (2015-10-01)

Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I.
by: T P Leren, et al.
Published: (1997-01-01)

ApoA-II/apoA-I molar ratio in the HDL particle influences phospholipid transfer protein-mediated HDL interconversion.
by: P J Pussinen, et al.
Published: (1997-01-01)

Characterization of phospholipids in pre-α HDL: selective phospholipid efflux with apolipoprotein A-I
by: Wenwu Zhang, et al.
Published: (1998-08-01)

Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux.
by: Georgios Daniil, et al.
Published: (2013-01-01)

Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis
by: Eftaxia-Konstantina Valanti, et al.
Published: (2018-10-01)

Therapies to Increase ApoA-I and HDL-Cholesterol Levels
by: William M. Brown, et al.
Published: (2008-01-01)

Therapies to Increase ApoA-I and HDL-Cholesterol Levels
by: William M. Brown J.D., Ph.D., et al.
Published: (2008-01-01)

Formation of new HDL particles from lipid-free apolipoprotein A-I.
by: M A Clay, et al.
Published: (1996-01-01)

Correction: Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux
by: The Staff
Published: (2014-01-01)

Correction: Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux.
Published: (2014-01-01)

Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression
by: Fayanne E. Thorngate, et al.
Published: (2003-12-01)

Characterization of nascent HDL particles and microparticles formed by ABCA1-mediated efflux of cellular lipids to apoA-I
by: Phu T. Duong, et al.
Published: (2006-04-01)

Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apoA-I transgenic rats.
by: N Fournier, et al.
Published: (1996-01-01)

Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome[S]
by: Fabiana Rached, et al.
Published: (2014-12-01)

HDL-apoA-I exchange: rapid detection and association with atherosclerosis.
by: Mark S Borja, et al.
Published: (2013-01-01)

Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I
by: Marie-Claude Blatter Garin, et al.
Published: (2006-03-01)

SAA-only HDL formed during the acute phase response in apoA-I+/+ and apoA-I–/– mice
by: Veneracion G. Cabana, et al.
Published: (1999-06-01)

ABCA1-dependent lipid efflux to apolipoprotein A-I mediates HDL particle formation and decreases VLDL secretion from murine hepatocytes
by: Daisy Sahoo, et al.
Published: (2004-06-01)

An apoA-I mimetic peptibody generates HDL-like particles and increases alpha-1 HDL subfraction in mice
by: Shu-Chen Lu, et al.
Published: (2012-04-01)

HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial
by: Ruth Blanco-Rojo, et al.
Published: (2017-10-01)

Characterization and properties of preβ-HDL particles formed by ABCA1-mediated cellular lipid efflux to apoA-I*
by: Phu T. Duong, et al.
Published: (2008-05-01)

Small HDL particles containing two apoA-I molecules are precursors in vivo to medium and large HDL particles containing three and four apoA-I molecules in nonhuman primates
by: Perry L. Colvin, et al.
Published: (1999-10-01)

Immunochemical Approach for Monitoring of Structural Transition of ApoA-I upon HDL Formation Using Novel Monoclonal Antibodies
by: Hitoshi Kimura, et al.
Published: (2017-06-01)

Direct detection of ABCA1-dependent HDL formation based on lipidation-induced hydrophobicity change in apoA-I[S]
by: Risa Omura, et al.
Published: (2014-11-01)

ApoA-IV promotes the biogenesis of apoA-IV-containing HDL particles with the participation of ABCA1 and LCAT[S]
by: Adelina Duka, et al.
Published: (2013-01-01)

Cell surface-expressed moesin-like HDL/apoA-I binding protein promotes cholesterol efflux from human macrophages
by: Akifumi Matsuyama, et al.
Published: (2006-01-01)

On the hepatic mechanism of HDL assembly by the ABCA1/apoA-I pathway
by: Maki Tsujita, et al.
Published: (2005-01-01)

Circulating HDL levels control hypothalamic astrogliosis via apoA-I
by: Anna Götz, et al.
Published: (2018-09-01)

Increased prebeta-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes.
by: O L Francone, et al.
Published: (1996-01-01)

Limited proteolysis of a disulfide-linked apoA-I dimer in reconstituted HDL
by: Laura Calabresi, et al.
Published: (2001-06-01)

ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity
by: Mengdie Luo, et al.
Published: (2017-05-01)

HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
by: Kuang-Yuh eChyu, et al.
Published: (2015-09-01)

In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions
by: Catherine C. Hedrick, et al.
Published: (2001-04-01)

Multiple dysfunctions of two apolipoprotein A-I variants, apoA-I(R160L)Oslo and apoA-I(P165R), that are associated with hypoalphalipoproteinemia in heterozygous carriers
by: Ulrike Daum, et al.
Published: (1999-03-01)

Significance of the hydrophobic residues 225–230 of apoA-I for the biogenesis of HDL1[S]
by: Panagiotis Fotakis, et al.
Published: (2013-12-01)

Three-dimensional models of HDL apoA-I: implications for its assembly and function*
by: Michael J. Thomas, et al.
Published: (2008-09-01)

Apolipoprotein composition and particle size affect HDL degradation by chymase: effect on cellular cholesterol efflux
by: Miriam Lee, et al.
Published: (2003-03-01)

Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity
by: Katya B. Rubinow, et al.
Published: (2012-07-01)